A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with non-diabetic chronic ...
Purpose
Category
Urinary Tract and Kidney
IRB Number
20210618HU
NCT Number
-
Sponsor
-
Study Contact
Principal Investigator
Shweta Bansal
Jonathan Polanco
210-450-9097
polancoj@uthscsa.edu